Hillcrest Asset Management’s Emergent Biosolutions EBS Stock Holding History

Hillcrest Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$8M	Sell	184,010 -26,370	-13%	-$1.19M	1.22%	52
2021 Q3	$10.5M	Buy	210,380 +74,972	+55%	+$4.54M	1.51%	39
2021 Q2	$8.53M	Sell	135,408 -25,330	-16%	-$1.63M	1.15%	54
2021 Q1	$14.9M	Sell	160,738 -690	-0.4%	-$70.7K	1.74%	27
2020 Q4	$14.5M	Sell	161,428 -398	-0.2%	-$36.5K	1.97%	15
2020 Q3	$16.7M	Sell	161,826 -4,367	-3%	-$471K	2.96%	3
2020 Q2	$13.1M	Sell	166,193 -54,467	-25%	-$4.06M	2.4%	8
2020 Q1	$12.8M	Buy	220,660 +1,450	+0.7%	+$83.6K	3.07%	6
2019 Q4	$11.8M	Buy	219,210 +38,562	+21%	+$2.09M	1.8%	29
2019 Q3	$9.44M	Sell	180,648 -5,440	-3%	-$253K	1.51%	40
2019 Q2	$8.99M	Buy	186,088 +1,130	+0.6%	+$54.2K	1.4%	45
2019 Q1	$9.34M	Buy	184,958 +49,322	+36%	+$2.91M	1.5%	42
2018 Q4	$8.04M	Buy	135,636 +30	+0%	+$1.93K	1.93%	21
2018 Q3	$8.93M	Buy	135,606 +20,204	+18%	+$1.18M	1.7%	34
2018 Q2	$5.83M	Sell	115,402 -1,096	-0.9%	-$57.1K	1.09%	54
2018 Q1	$6.13M	Buy	+116,498	New	+$5.81M	1.23%	51

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hillcrest Asset Management's EBS Position: Q4 2021 in Review

Hillcrest Asset Management reduced its Emergent Biosolutions (EBS) stake by 13% in Q4 2021, selling an estimated $1.19M and leaving 184,010 shares worth $8M. The position accounts for 1.22% of the portfolio, ranked #52.

Hillcrest Asset Management first reported a position in EBS in Q1 2018 and has held it in 16 quarters since. The position peaked at $16.7M in Q3 2020. 253 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

Hillcrest Asset Management held 184,010 shares of Emergent Biosolutions worth $8M as of Q4 2021.
Hillcrest Asset Management sold 26,370 Emergent Biosolutions shares in Q4 2021, an estimated $1.19M.
Emergent Biosolutions made up 1.22% of Hillcrest Asset Management's portfolio in Q4 2021, its #52 holding.
Hillcrest Asset Management first reported a position in Emergent Biosolutions in Q1 2018 and has held it in 16 quarters since.
Hillcrest Asset Management's Emergent Biosolutions position peaked at $16.7M in Q3 2020.
253 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Hillcrest Asset Management's 13F filing for Q4 2021, filed 24 Feb 2022.